[Should patients be informed of potential but not confirmed risks of cancer linked to menopausal hormone replacement treatment?].
Elia
D
D
Jamin
C
C
D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D007258:Informed Consent; D009369:Neoplasms / Q000139:chemically induced*; D010353:Patient Education as Topic
Doit-on prévenir les patientes des risques éventuels et non confirmés de cancer liés au traitment hormonal substitutif (THS) de la ménopause.